Robin Wright - Net Worth and Insider Trading
Robin Wright Net Worth
The estimated net worth of Robin Wright is at least $64,663 dollars as of 2024-11-05. Robin Wright is the Director of Barinthus Biotherapeutics PLC and owns about 48,256 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $64,663. Details can be seen in Robin Wright's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robin Wright has not made any transactions after 2023-05-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robin Wright
Robin Wright Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robin Wright owns 1 companies in total, including Barinthus Biotherapeutics PLC (BRNS) .
Click here to see the complete history of Robin Wright’s form 4 insider trades.
Insider Ownership Summary of Robin Wright
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BRNS | Barinthus Biotherapeutics PLC | 2023-05-25 | director |
Robin Wright Latest Holdings Summary
Robin Wright currently owns a total of 1 stock. Robin Wright owns 48,256 shares of Barinthus Biotherapeutics PLC (BRNS) as of May 25, 2023, with a value of $64,663.
Latest Holdings of Robin Wright
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BRNS | Barinthus Biotherapeutics PLC | 2023-05-25 | 48,256 | 1.34 | 64,663 |
Holding Weightings of Robin Wright
Robin Wright Form 4 Trading Tracker
According to the SEC Form 4 filings, Robin Wright has made a total of 3 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the acquisition of 13,750 shares on May 25, 2023, which cost Robin Wright around $36,575.
Insider Trading History of Robin Wright
- 1
Robin Wright Trading Performance
GuruFocus tracks the stock performance after each of Robin Wright's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robin Wright is -17.01%. GuruFocus also compares Robin Wright's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robin Wright within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robin Wright's insider trading performs compared to the benchmark.
Performance of Robin Wright
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.58 | | | | | |
| Relative Return to S&P 500(%) | -2.56 | | | | | |
Robin Wright Ownership Network
Ownership Network List of Robin Wright
Ownership Network Relation of Robin Wright
Robin Wright Owned Company Details
What does Barinthus Biotherapeutics PLC do?
Who are the key executives at Barinthus Biotherapeutics PLC?
Robin Wright is the director of Barinthus Biotherapeutics PLC. Other key executives at Barinthus Biotherapeutics PLC include director & Chief Executive Officer William Enright , Chief Scientific Officer Nadege Pelletier , and Chief Financial Officer Gemma Brown .
Barinthus Biotherapeutics PLC (BRNS) Insider Trades Summary
Over the past 18 months, Robin Wright made 1 insider transaction in Barinthus Biotherapeutics PLC (BRNS) with a net purchase of 13,750. Other recent insider transactions involving Barinthus Biotherapeutics PLC (BRNS) include a net purchase of 10,000 shares made by Joseph Scheeren ,
In summary, during the past 3 months, insiders sold 0 shares of Barinthus Biotherapeutics PLC (BRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Barinthus Biotherapeutics PLC (BRNS) were sold and 23,750 shares were bought by its insiders, resulting in a net purchase of 23,750 shares.
Barinthus Biotherapeutics PLC (BRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Barinthus Biotherapeutics PLC Insider Transactions
Robin Wright Mailing Address
Above is the net worth, insider trading, and ownership report for Robin Wright. You might contact Robin Wright via mailing address: The Schrodinger Building, Heatley Road, The Oxford Science Park, Oxford X0 Ox4 4ge.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
